Dhampur Bio Organics Ltd

Dhampur Bio Organics Ltd has announced the payment of its final dividend for the Financial Year 2025-26. Shareholders approved a dividend of 15%, equivalent to ₹1.50 per equity share of ₹10 face value, at the Annual General Meeting held on July 24, 2026. The dividend amount has been remitted to shareholders via NACH. The company has also deducted tax at source on dividends exceeding ₹10,000. Shareholders facing non-receipt or discrepancies are advised to contact the Registrar and Share Transfer Agent, Alankit Assignments Limited.

Sonitron Limited, a promoter company, has acquired 25,000 equity shares of Dhampur Bio Organics Limited through open market purchases. This transaction increases Sonitron's shareholding in Dhampur Bio Organics from 17.293% to 17.331%. The acquisition was made on August 5, 2026, and reported under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The total equity share capital of Dhampur Bio Organics remains unchanged at 6,63,87,590 equity shares of Rs. 10 each.

Sonitron Limited has acquired an additional 25,000 equity shares of Dhampur Bio Organics Limited through open market transactions. This acquisition represents approximately 0.038% of the total share capital. Following this transaction, Sonitron Limited's total holding in Dhampur Bio Organics Limited now stands at 1,15,05,499 equity shares, constituting 17.331% of the company's total share capital. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Mr. Lalit Dalal, Vice President - Finance & Accounts of Dhampur Bio Organics Ltd, has resigned from his position effective July 31, 2026. The resignation is to pursue career opportunities outside the organization. The company has provided disclosures as required by SEBI (LODR) Regulations, 2015, including the reason for change and cessation date. Annexure A details the disclosures, and Annexure B contains the resignation letter.

Sonitron Limited, a promoter company, has acquired 3,719 equity shares of Dhampur Bio Organics Limited through open market purchases. This acquisition, effective July 24, 2026, represents a minor increase of 0.006% in Sonitron's shareholding. Following the transaction, Sonitron Limited's total holding in Dhampur Bio Organics stands at 1,14,74,950 shares, constituting 17.285% of the total equity share capital. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sonitron Limited has disclosed a substantial acquisition of shares in Dhampur Bio Organics Limited, as per SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The acquisition, conducted via the open market, increased Sonitron's holding to 17.285% of the total share capital. Prior to this transaction, Sonitron held 17.279% of Dhampur Bio Organics' equity shares. The total equity share capital of Dhampur Bio Organics remains at 6,63,87,590 equity shares of Rs. 10 each.

Dhampur Bio Organics Ltd announced the re-appointment of its Internal Auditor for the financial year 2026-27 following a Board of Directors meeting held on July 14, 2026. The board also approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. Additionally, the company decided not to declare an interim dividend for the current period. The financial results and details regarding the auditor appointment have been submitted as per SEBI Listing Regulations and will be uploaded on the company's website.

Dhampur Bio Organics Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results at a meeting held on July 14, 2026. The company also decided not to declare an interim dividend for the period. Additionally, the Board approved the appointment of the Internal Auditor for the financial year 2026-27. The financial results and limited review report have been submitted and will be published in newspapers as per regulations.

Dhampur Bio Organics reported a consolidated net profit of ₹36.79 Cr for Q1 FY27 (EPS ₹5.59), reversing a ₹22.00 Cr loss in the year-ago quarter. The reversal is not operational: it rests entirely on a ₹63.89 Cr gain from the slump-sale of the Meerganj (Bareilly) sugar and co-generation unit for ₹305 Cr, transferred June 18, 2026 and classified under discontinued operations. Strip that one-off out and the group would have posted a net loss of roughly ₹27 Cr — wider than last year's ₹22 Cr loss (~-23% adjusted). Continuing operations alone lost ₹13.75 Cr after tax on a ₹18.29 Cr pre-tax loss, only marginally better than the ₹20.88 Cr pre-tax loss a year ago. Continuing-operations revenue rose ~22% YoY to ₹918.56 Cr (₹750.64 Cr) and ~33% sequentially, but this is a seasonal print — management explicitly flags that a single sugar quarter is not representative of the year. The mix shifted sharply: Country Liquor nearly doubled to ₹489.08 Cr and is now the largest segment, while Sugar (₹371.32 Cr) and Bio Fuels & Spirits (₹80.78 Cr) both shrank YoY. Profitability is the problem — total segment results were just ₹12.54 Cr (1.4% of revenue), and finance costs of ₹15.56 Cr alone more than wiped that out, keeping the core business in the red despite higher sales; net margin excluding the one-off is negative. Alongside the result, the board acquired a 74% stake in DBION Pvt Ltd (July 9), reappointed Grant Thornton Bharat as internal auditor and declared no interim dividend; the numbers are unaudited (limited review, unmodified conclusion). The company gives no formal guidance and there is no brokerage consensus on record for a stock of this size, so there is no street or guidance benchmark to measure against. Net read: the headline profit is a portfolio-restructuring event — exiting a sugar unit — not a turn in the underlying business, which stayed loss-making even as revenue grew.

Dhampur Bio Organics Ltd has successfully completed the acquisition of 74% of the equity shares in DBION Private Limited (formerly Sonitron Chemicals Private Limited). The acquisition involved 7400 equity shares at Rs. 10 each, totaling Rs. 74,000. This strategic move, in line with a Joint Venture Agreement with Orgonew Private Limited, makes DBION Private Limited a subsidiary of Dhampur Bio Organics and a Joint Venture Company. Previous intimations regarding this acquisition were made on April 20, 2026, May 30, 2026, and June 04, 2026.